Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease
- PMID: 20823135
- PMCID: PMC2995570
- DOI: 10.3324/haematol.2010.028829
Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease
Abstract
Background: Donor T lymphocytes are directly responsible for graft-versus-host disease. Molecules important in T-cell function may, therefore, be appropriate targets for graft-versus-host disease therapy and/or prophylaxis. Here we analyzed whether nuclear factor-κ B inducing kinase might have a role in graft-versus-host disease.
Design and methods: We studied the expression of nuclear factor-κ B inducing kinase in human samples from patients with graft-versus-host disease. We also explored the effect of nuclear factor-κ B inducing kinase in a murine model of graft-versus-host disease using donor cells from aly/aly mice (deficient in nuclear factor-κ B inducing kinase) and C57BL/6 mice (control).
Results: We detected expression of nuclear factor-κ B inducing kinase in T-lymphocytes in the pathological lesions of patients with acute graft-versus-host disease. Mice transplanted with aly/aly T lymphocytes did not develop graft-versus-host disease at all, while mice receiving C57BL/6 cells died of a lethal form of the disease. Deficiency of nuclear factor-κ B inducing kinase did not affect the engrafting ability of donor T cells, but severely impaired their expansion capacity early after transplantation, and aly/aly T cells showed a higher proportion of apoptosis than did C57BL/6 T cells. Effector T lymphocytes were the T-cell subset most affected by nuclear factor-κ B inducing kinase deficiency. We also detected lower amounts of inflammatory cytokines in the serum of mice receiving aly/aly T cells than in the serum of mice receiving C57BL/6 T cells.
Conclusions: Our results show that nuclear factor-κ B inducing kinase has a role in graft-versus-host disease by maintaining the viability of activated alloreactive T lymphocytes.
Figures





Similar articles
-
Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.Immunology. 2015 Sep;146(1):89-99. doi: 10.1111/imm.12484. Epub 2015 Jun 25. Immunology. 2015. PMID: 25988531 Free PMC article.
-
Significant involvement of nuclear factor-κB-inducing kinase in proper differentiation of αβ and γδ T cells.Immunology. 2014 Feb;141(2):222-32. doi: 10.1111/imm.12186. Immunology. 2014. PMID: 24117043 Free PMC article.
-
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.Blood. 2009 Dec 3;114(24):5062-70. doi: 10.1182/blood-2009-06-227587. Epub 2009 Oct 14. Blood. 2009. PMID: 19828695 Free PMC article.
-
Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.Oncotarget. 2017 Apr 4;8(14):23360-23375. doi: 10.18632/oncotarget.15579. Oncotarget. 2017. PMID: 28423578 Free PMC article.
-
Are graft-versus-host-disease patients missing out on the vital occupational therapy services? a systematic review - Erratum.Int J Rehabil Res. 2022 Dec 1;45(4):370. doi: 10.1097/MRR.0000000000000553. Epub 2022 Sep 1. Int J Rehabil Res. 2022. PMID: 36321216 No abstract available.
Cited by
-
JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK/STAT and ROS-MAPK/NF-κB signalling pathways in acute graft-versus-host disease.Clin Transl Immunology. 2023 Feb 25;12(2):e1441. doi: 10.1002/cti2.1441. eCollection 2023. Clin Transl Immunology. 2023. PMID: 36855558 Free PMC article.
-
NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation.J Immunol. 2012 May 1;188(9):4602-10. doi: 10.4049/jimmunol.1200021. Epub 2012 Apr 2. J Immunol. 2012. PMID: 22474019 Free PMC article.
-
Role of T cell-nuclear factor κB in transplantation.Transplant Rev (Orlando). 2012 Jul;26(3):189-200. doi: 10.1016/j.trre.2011.07.005. Epub 2011 Nov 8. Transplant Rev (Orlando). 2012. PMID: 22074783 Free PMC article. Review.
-
NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses.J Exp Med. 2011 Aug 29;208(9):1917-29. doi: 10.1084/jem.20110128. Epub 2011 Aug 1. J Exp Med. 2011. PMID: 21807870 Free PMC article.
-
Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models.Bone Marrow Transplant. 2014 May;49(5):649-56. doi: 10.1038/bmt.2014.20. Epub 2014 Mar 3. Bone Marrow Transplant. 2014. PMID: 24583628
References
-
- Thomas ED. Bone marrow transplantation: a review. Semin Hematol. 1999;36(4 Suppl 7):95–103. - PubMed
-
- Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol. 2007;7(5):340–52. - PubMed
-
- Ferrara JLM, Cooke KR, Teshima T. The pathophysiology of graft-vs-host disease. In: Ferrara J, Cooke K, Deeg J, editors. Graft-vs-Host Disease. 3rd edition. New York: Marcel Dekker; 2005. pp. 1–34.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources